FSA Wealth Management’s GSK GSK Stock Holding History

FSA Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.86K	Hold	66	–	–	﹤0.01%	469
2025 Q2	$2.55K	Hold	66	–	–	﹤0.01%	454
2025 Q1	$2.57K	Hold	66	–	–	﹤0.01%	424
2024 Q4	$2.24K	Hold	66	–	–	﹤0.01%	477
2024 Q3	$2.71K	Buy	+66	New	+$2.7K	﹤0.01%	460
2024 Q1	$6.27K	Hold	146	–	–	﹤0.01%	411
2023 Q4	$5K	Buy	+146	New	+$5.24K	﹤0.01%	422
2020 Q3	–	Sell	-168	Closed	-$9K	–	173
2020 Q2	$9K	Hold	168	–	–	0.01%	274
2020 Q1	$8K	Hold	168	–	–	0.01%	264
2019 Q4	$10K	Buy	+168	New	+$9.35K	0.01%	303

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FSA Wealth Management's GSK Position: Q3 2025 in Review

FSA Wealth Management held its GSK (GSK) position steady in Q3 2025 at 66 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

FSA Wealth Management first reported a position in GSK in Q4 2019 and has held it in 10 quarters since. The position peaked at $10K in Q4 2019. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

FSA Wealth Management held 66 shares of GSK worth $2.86K as of Q3 2025.
FSA Wealth Management left its GSK share count unchanged in Q3 2025.
GSK made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #469 holding.
FSA Wealth Management first reported a position in GSK in Q4 2019 and has held it in 10 quarters since.
FSA Wealth Management's GSK position peaked at $10K in Q4 2019.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.